BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29376856)

  • 1. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
    Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
    Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
    Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
    Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer's Disease Mice.
    Fonar G; Polis B; Sams DS; Levi A; Malka A; Bal N; Maltsev A; Elliott E; Samson AO
    Mol Neurobiol; 2021 May; 58(5):2322-2341. PubMed ID: 33417228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
    Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
    Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
    Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
    Farhat SM; Ahmed T
    Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using
    Coughlin JM; Rubin LH; Du Y; Rowe SP; Crawford JL; Rosenthal HB; Frey SM; Marshall ES; Shinehouse LK; Chen A; Speck CL; Wang Y; Lesniak WG; Minn I; Bakker A; Kamath V; Smith GS; Albert MS; Azad BB; Dannals RF; Horti A; Wong DF; Pomper MG
    J Nucl Med; 2020 Mar; 61(3):423-426. PubMed ID: 31420499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.